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Objectives: Dental status, dental treatment procedures and radiotherapy dosage as potential risk factors for an
infected osteoradionecrosis (IORN) in patients with oral cancers: Retrospective evaluation of 204 patients treated in
two observation periods of approximately ten years each.
Patients and methods: In group A, 90 patients were treated in the years 1993-2003, in group B 114 patients in the
years 1983-1992 (data in brackets). All patients had histopathologically proven squamous cell cancers, mainly UICC
stages III and IV. 70% (85%, n.s.) had undergone surgery before radiotherapy. All patients were referred to the oral
and maxillofacial surgeon for dental rehabilitation before further treatment.
Radiotherapy was performed using a 3D-conformal technique with 4-6MV photons of a linear accelerator (Co-60
device up to 1987). The majority of patients were treated using conventional fractionation with total doses of 60-70
Gy in daily fractions of 2 Gy. Additionally, in group A, hyperfractionation was used applying a total dose of 72 Gy in
fractions of 1.2 Gy twice daily (time interval > 6 hours). In group B, a similar schedule was used up to a total dose of
82.8 Gy (time interval 4-6 hours). 14 (0) patients had radiochemotherapy simultaneously. After therapy, the patients
were seen regularly by the radiooncologist and – if necessary – by the oral and maxillofacial surgeon. The duration
of follow-up was 3.64 years (5 years, p = 0.004).
Results: Before radiotherapy, the dental health status was very poor. On average, 21.5 (21.2, n.s.) teeth were
missing. Further 2.04 teeth (2.33, n.s.) were carious, 1.4 (0.3, p = 0.002) destroyed.
Extractions were necessary in 3.6 teeth (5.8, p = 0.008), conserving treatment in 0.4 (0.1, p = 0.008) teeth. After dental
treatment, 6.30 (4.8, n.s.) teeth remained.
IORN was diagnosed after conventionally fractionated radiotherapy in 15% (11%, n.s.), after hyperfractionation in 0%
(34%, p = 0.01).
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Conclusion: Within more than 20 years there was no improvement in dental status of oral cancer patients.
Extensive dental treatment procedures remained necessary. There was an impressive reduction of the IORN
frequency in patients treated in a hyperfractionated manner probably resulting from a dose reduction and an
extension of the interfraction time.
Keywords: Oral cancer; Radiotherapy; Infected osteoradionecrosis; Dental statusBackground
Infected osteoradionecrosis (IORN) is still one of the
major problems after radiotherapy for neoplasms in the
oral cavity. The chewing and swallowing functions of the
patients are impaired, long-lasting conservative and surgi-
cal interventions may become necessary. In the last de-
cades, there was an ample discussion about potential risk
factors for the development of IORN. Besides the kind of
surgical procedures, dosage and fractionation of radiother-
apy and the simultaneous application of chemotherapy,
the patients’ dental status before treatment and the extent
of dental treatment procedures were regarded significant.
Thus, more than 20 years ago, the departments of
Radiotherapy and of Oral and Maxillofacial Surgery of
the Saarland University Medical School together started
a dental examination and rehabilitation program with
the aim to prevent IORN as far as possible. All patients
referred for radiotherapy for cancer in the oral cavity
were examined by the oral and maxillofacial surgeon,
the exact dental findings were recorded and – if neces-
sary, specific rehabilitation procedures were performed.
Radiotherapy was started only after approval by the Oral
and maxillofacial surgeon (OMF surgeon). After therapy,
the patients were seen regularly by the radiooncologist,
diagnosis and treatment of IORN were performed by the
oral and maxillofacial surgeon.
After completion of two theses (Barbie 1997; Mang
2011), published in (Niewald et al. 1996; Niewald et al.
2013) each analyzing a ten years’ period of radiotherapy
for oral cancer one after the other, we now had the unique
possibility to reanalyze and to compare the data obtained
in this very long observation period in terms of dental
findings, dental rehabilitation procedures and the fre-
quency of IORN.
Methods
Two groups of patients who had undergone radiotherapy
for neoplasms of the oral cavity have been reanalyzed
retrospectively:
Group A consists of 90 consecutive patients having
been treated in the years 1993-2003.
Group B consists of 114 consecutive patients having
been treated in the years 1983-1992 (data in brackets).All patients suffered from squamous cell carcinoma of
the oral cavity mainly in stages III and IV according to the
Union Internationale contre le Cancer-(UICC)-definition,
one patient had a local recurrence but had not been ir-
radiated before. Patients with treated local or regional
recurrences, distant metastases or with insufficient data
were excluded. In group B, it seemed impossible to
actualize the follow-up data, so that the data from the
former analysis were taken. For this reason, no compari-
son of oncological results was attempted. In order to
improve comparability, the inclusion criteria mentioned
above were applied to both groups retrospectively which
lead to the exclusion of several patients and a complete
re-analysis of the data.
70% of the patients in group A (85%, n.s.) had under-
gone surgery for the primary tumor and the regional
lymph node regions. After surgery or after biopsy all pa-
tients were referred to the oral and maxillofacial surgeon
for assessment of the dental status including an meticu-
lous clinical and x-ray examination. The dental treatment
procedures were performed as early as possible with a
minimal time interval of 7-10 days from the last procedure
to the beginning of radiotherapy. All dental extractions
were performed according to a written protocol under
“special care” (primary tissue closure, perioperative antibi-
otics for 7-10 days beginning one day before surgery). In
the nineties all patients were advised not to wear their
dental prostheses up to 6-12 months after radiotherapy
(today until complete healing of mucositis) (Curi and Dib
1997; Reuther et al. 2003). Radiotherapy was started
after complete healing of the gingival wounds and thus
approval by the OMF surgeon.
After production of a face mask for fixation, the
computerized tomography for radiotherapy planning was
performed, and the two- dimensional (up to 2000) or
three-dimensional dose distribution was computed after
target volume delineation. Radiotherapy was applied
using 4-6MV photons (electrons for level V lymph node
region) of a linear accelerator; a 60-Cobalt machine was
in use additionally until 1987. In the majority of patients
(n = 73 in group A, n = 74 in group B), conventionally
fractionated radiotherapy was applied with total doses
of 60-70 Gy (details see Table 1) in daily single fractions of
2 Gy. Furthermore, different hyperfractionated schedules
Table 1 Biographical and oncological data
Item Group A Group B Remarks
Mean age (years) 57.1 54.6 n.s.
Mean Karnofsky performance Index 7.8 7.5 n.s.
Follow-up (years) 4.1 5.0 p = 0.004
T-stage T1 14 (16%) 20 (18%) n.s.
T2 33 (37%) 49 (43%)
T3 8 (9%) 19 (16%)
T4 35 (38%) 26 (23%)
N-stage N0 20 (22%) 46 (40%) n.s.
N1 23 (26%) 24 (21%)
N2 47 (52%) 30 (26%)
N3 0 14 (13%)
UICC stage I 6 ( 7%) 10 ( 9%) n.s.
II 7 (8%) 22 (19%)
III 19 (21%) 26 (23%)
IV 58 (64%) 56 (49%)
Pre-treatment None 24 (27%) 17 (15%) p < 0.001
Surgery 66 (73%) 97 (85%)
Total dose (Gy) Conventional fractionation N = 75 N = 73 p < 0.001
30Gy (1) 2Gy (1)
36Gy (1) 8Gy (1)
50Gy (7) 36Gy (1)
58Gy (2) 44Gy (1)
60Gy (32) 56Gy (1)
64Gy (9) 60Gy (31)






Total dose (Gy) Hyperfractionation N = 15 N = 41
55.8Gy (1) 13.2Gy (1)
70.8Gy (1) 81.6Gy (2)
72.0Gy (11) 82.8Gy (35)
72.8Gy (1) 85.2Gy (1)
76.8Gy (1) 85.5Gy (1)
87.8Gy (1)
Daily fraction Conventional fractionation 2.0 Gy (74) 2.0Gy (73) p = 0.0012
3.0 Gy (1)
Hyperfractionation 1.2 Gy (14) 1.2 Gy (41)
1.4 Gy (1)
Simultaneous chemotherapy 14 0 p < 0.001
Niewald et al. SpringerPlus 2014, 3:263 Page 3 of 12
http://www.springerplus.com/content/3/1/263
Niewald et al. SpringerPlus 2014, 3:263 Page 4 of 12
http://www.springerplus.com/content/3/1/263were performed in both groups: in group A (n = 46) a total
dose of 72 Gy was applied in single doses of 1.2 Gy twice
daily (interfraction interval > =6 hours) to patients with
formerly untreated tumors, in group B (n = 41) a total
dose of 82.8 Gy in single doses of 1.2 Gy twice daily (inter-
fraction interval 4-6 hours) was applied to patients with
untreated and with resected tumors. Two patients in
group A have been treated in a different manner (one with
1.4 Gy twice daily, another with a single dose of 3.0 Gy
once daily).
14(0) patients received chemotherapy consisting of cis-
platinum and 5-FU simultaneously due to their un-
favourable tumour and nodal stage. No patients with
chemotherapy were excluded from the evalution. During
therapy, the patients received dental care by the local
dental colleagues. Fluoridation was used according to
dental advice. Splints were not normally used because of
unfavourable experience of patients with aggravating ra-
diation mucositis by applying fluoride jelly to the gingiva
using these splints.
After radiotherapy, the patients were examined for
locoregional result and possible side effects in the De-
partment of Radiotherapy and Radiooncology. Dental
follow-up was performed by their local dentists. Conse-
quently, detailed data about this phase are not available.
Patients with a suspicion of IORN were referred to the
Dept. of Oral and Maxillofacial Surgery for further diag-
nosis and treatment.Table 2 Dental findings before radiotherapy




Deeply carious destroyed 1.4 0.3
Loose 1.6 2.2
Root remainders 0.3 0.4
Devital 0.5 1.0
Roots – filled completely 0.2 0.1
Roots – filled incompletely 0.3 0.1
Apical periodontitis 0.3 0.2
Dentogenic cysts 0.2 0.1
Retained teeth 0.2 0.1
Superficial marginal periodontitis (patients)
- Localized 7 (8%) 33 (
- General 10 (11%) 16 (
Profound marginal periodontitis (patients)
- Localized 12 (14%) 25 (
- General 35 (40%) 14 (
Superficial marginal periodontitis: chronic periodontitis with less to moderate attatc
Profound marginal periodontitis: chronic periodontitis with severe attatchment lossThe mean duration of follow-up was 3.64 years (5 years,
p = 0.004).
Infected osteoradionecrosis was minimally diagnosed
when necrosis of the gingiva on top of the eroded bone
became visible as infected mucosal ulcers with eroded
mandibular bone underneath according to grade 2 or
higher of the classification published by Schwartz et al.
(Schwartz and Kagan 2002). Patients with manifest IORN
were treated by the oral and maxillofacial surgeon in
cooperation with the local dentist.
The patients’ data were collected from the records in
the Departments of Radiotherapy and Radiooncology
and Oral and Maxillofacial Surgery. All (panoramic x-ray)
examinations available have been reviewed, thus we are
quite sure that a potential local recurrence has not been
misdiagnosed as an IORN. Furthermore, standardized
questionnaires were mailed to the patients’ general
medical practitioners and general dentists as well as the
local authorities five times within the observation period
in order to get additional data about freedom of local or
regional recurrence, survival or the onset of IORN.
All data were entered into a medical databank (Medlog™,
Parox, Muenster, Germany). Frequency distributions,
means and standard deviations were computed. The
groups were compared using the t-test (means) and the
Kruskal-Wallace test (distributions). Overall survival
and occurrence of IORN over time were computed




p = 0.002 200
n.s. 197
n.s. 202
p = 0.023 200
n.s. 198




29%) p = 0.002 199
14%)




Table 3 Dental rehabilitation procedures
Teeth (mean values, n=) Group A Group B Comparison Data available from n patients
Endodontic treatment 0.05 0.03 n.s. 200
Removal of root remainders 0.2 0.4 n.s. 200
Tooth extraction 3.7 5.8 p = 0.008 202
Conserving treatment 0.6 0.1 p = 0.008 200
Cystectomy 0.09 0.05 n.s. 199
Surgical removal 0.3 0.2 n.s. 201
Healthy teeth remaining after dental rehabilitation 6.2 4.8 n.s. 201
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Prognostic parameters for IORN were analyzed univari-
ately by comparison of means and distributions in a
group containing the patients with IORN compared to
another group with the patients who never experienced
IORN using the t-test, u-test and chi-square test in the
appropriate variables. Multivariate search for inde-
pendent prognostic factors was performed by logistic
regression.
Detailed biographical and oncological data have been
summarized in Table 1.
All patients had given their written informed consent
before dental examination and treatment as well as
radiotherapy. The approval by the local ethics committee
was dispensable due to the retrospective nature of this
evaluation. This research is in compliance with the
Declaration of Helsinki in its actual version.
Results
General remarks
In group A, up to July 2013, 58 patients were dead with
a mean follow-up of 2.4 [0-8.8] years. The patientsFigure 1 Development of IORN over time (Kaplan-Meier estimate).known to be alive were seen irregularly, the most recent
information resulted from questionnaires, nearly all
patients were lost to follow-up after on average 7.4
[0-15] years.
In group B, 77/114 patients were dead with a mean
follow-up of 3.4 [0-11.7] years. The patients known alive
were lost to follow-up after on average 8.5 [4.3-13.3]
years.
Dental findings before radiotherapy
The patients’ dental status was generally poor. On aver-
age 10.1 (10.8) teeth were found present at the time of
initial dental examination. For most of the criteria there
was no statistically significant difference between the
groups. However, we found significantly more destroyed
teeth (1.4 vs. 0.3 teeth, p = 0.002) in the more recent pa-
tient collective, Furthermore there were more roots filled
incompletely (0.3 vs. 0.1 teeth, p = 0.006). However, avital
teeth were found less frequently in group A (0.5 vs. 1.0
teeth, p = 0.023). Chronic periodontitis with less to moder-
ate attachment loss was found less frequently (p = 0.01)
whereas chronic periodontitis with severe attachment












Roots – filled completely 0.949




Conservative treatment possible 0.430
No conservative treatment possible 0.179
Filled 0.751
Not sufficiently filled teeth 0.549
Teeth with not sufficient crowns 0.968
Item





Chronic periodontitis with severe attatchment loss 0.210
Localized
General
Dental treatment before radiotherapy
Endodontic treatment 0.379




Healthy teeth remaining after dental rehabilitation 0.158
Demographic and oncological data
Age 0.106
Karnofsky performance status 0.625
T-stage 0.222
N-stage 0.040 Significant
Total dose 0.005 Significant
BED2 0.040 Significant
Daily fraction 0.036 Significant
Table 4 Prognostic factors for the occurrence of IORN
(n = 204) (Continued)
Multivariate analysis





All remaining factors as mentioned in Tables 1 and 2 have been tested
univariately and found insignificant, thus they were not tested multivariately.
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compared to group B. Detailed data have been depicted
in Table 2.
We can summarize that dental status in these special
patients has hardly changed over the decades. Data con-
cerning dental biofilm or the use of dental prostheses
had not been collected in group B, thus a comparison
could not be performed.
Dental rehabilitation procedures
In the majority of criteria, the extent of dental rehabili-
tation procedures was identical in both groups. Tooth
extractions were found more frequently in group B (3.7
vs. 5.8, p = 0.008) whereas conserving treatment was
performed more frequently in Group A (0.6 vs. 0.1,
p = 0.008). Detailed data are summarized in Table 3.
Frequency and risk factors of infected osteoradionecrosis
(IORN)
IORN was found in the corpus region of the mandible
in 11/90 patients (12%) of group A and 22/114 patients
(19%) of group B (n.s.). The one-year prevalence was 5%,
the two- and three-year prevalence 15%. A subgroup
analysis dividing the collectives into two groups each
with the patients having been treated with conventional
fractionation or with hyperfractionation yielded the fol-
lowing results:
After conventional fractionation IORN was found in
group A in 11/74 patients (15%), in group B in 8/73 pa-
tients (11%, differences n.s.). After hyperfractionation,
IORN was not diagnosed in group A wheras it was ob-
served in 14/41 patients (34%) in group B (p = 0.01).
The Kaplan-Meier estimate showed that IORN normally
occurred in the first two years in group A (first five years
in group B) after radiotherapy (differences n.s.), after that
time the risk remained stable (Figure 1). The subgroup
analysis mentioned above resulted in identical curves for
patients irradiated conventionally and highly different (but
not statistically significant) curves after hyperfractionation.
The search for prognostically significant factors for the
occurrence of IORN was performed using the whole pa-
tient collective consisting of 204 patients. The number
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the daily fractions and the BED2 (Biologically effective
dose 2 Gy) were found prognostically significant in uni-
variate analysis. These factors were entered into the
multivariate analysis where solely the number of carious
teeth was found significant (details are depicted in Table 4).
The multivariate analysis showed the number of carious
teeth a nearly significant prognostic factor, furthermore,
the fractionation was found to be trendwise significant. All
further factors mentioned in Tables 1 and 2 tested univari-
ately were found insignificant. Further details are depicted
in Table 4.
We did not try to compare the oncological data like
local and regional tumor outcome or survival because
it seemed impossible to achieve reliable data for group
B nearly 20 years after treatment. Thus, we could not
correlate the frequency of IORN to a local recurrence.
Discussion
Dental health status and dental rehabilitation procedures
From our data we can summarize that – despite all ef-
fort in dental prophylaxis – the dental status of patients
with oral neoplasms did not improve” over decades nor
did the extent of dental rehabilitation procedures neces-
sary before the start of radiotherapy.
The comparison of our data to those of the Forth
German Trial of Oral Health (Kern et al. 2006) resulted
in marked differences: In this study adults (33-44 years
of age) on average 14.5 teeth were found carious, in
older people (> = 45 years of age) 22.1 teeth. These
teeth were rehabilitated completely in 95.6% and inTable 5 Dental status and rehabilitation procedures in the lit
Author group Dental status Rehabi
Frydrych and Slack-Smith 2011
(n = 82)
No information No info
Guggenheimer and Hoffman
1994 (n = 947)
Edentulous: 59% No info
Partially edentulous: 9%
Poor dentition with no
replacement: 14%
Intact dentition: 18%
Maier et al. 1993 (n = 100) Tumour vs. control patients:
Tartar > 3 mm: 40.91 vs. 21.98%
No info
Decayed teeth >50% : 27.2 vs.
3.9%
Lockhart and Clark 1994
(n = 131)
Alveolar bone loss: 66% Needing
Clinical caries: 71% Did not
treatme
Failing restorations: 91%
Jham et al. 2008 (n = 207) Periodontal disease: 41% No info
Residual root: 21.2%
Caries 12%
Unerupted tooth: 5.8%94.8%, respectively. A mean of 2.77 teeth in adults and
of 14.2 teeth in older people were missing. 72% of the
adults and 60.6% of the seniors were found to perform
sufficient mouth hygiene. All these values were improved
compared to the results of a former trial in 1997. On the
other hand, the frequency of periodontitis was rising
(moderate in 52.9% and intense in 39.8% of the popula-
tion). Compared to those data our findings in patients
with oral neoplasms were much more unfavourable and
did not improve over time.
Further equally detailed analyses were rare. Jham et al.
(Jham et al. 2008) reported in 2008 a collective of 207
patients with head and neck cancer with similar dental
findings to our investigation detecting periodontal dis-
ease in 41%, retained roots in 21%, carious teeth in 12%,
and unerupted teeth in 5.8% of their patients, resulting
in an IORN rate of 5.5%. Schuurhuis et al. summarized
2011 the data of 185 patients and found oral infectious
foci in 75%, a periodontal pocket depth of more than
6 mm in 23%, severe caries in 4%, impacted teeth in 4%,
and residual root tips in 3%. Tooth extractions had to be
performed in 30% of the patients, a mean of 7.7 teeth had
to be removed. Periodontal treatment was performed in
6%. IORN was diagnosed in 11% (Schuurhuis et al. 2011).
Further literature data on this topic have been summa-
rized in Table 5. In general, tumor patients frequently
showed a noncompliance in routine dental care and daily
oral hygiene. Tumor diagnosis did not change the patients’
habits: Lockhart and Clark stated in 1994 that 97% of their
patients needed dental care before radiotherapy, but only
81% underwent the indicated treatment.erature for IORN in the lower jaw
litation procedures Remarks
rmation Average (median) date of last dental visit:
66.76 months (18 months) before radiotherapy
rmation
rmation Tumour vs. control patients
Never tooth brushing 44.9 vs. 23.5%
Dental visit more than once a year: 6% vs. 43.5%
dental care: 97% Noncompliant with routine dental care: 76%
seek the indicated
nt: 81%
Noncompliant with routine oral hygiene: 65%
rmation
Table 6 Incidence of IORN of the upper and lower jaw in
the literature
Author group Incidence Remarks
Ben-David et al. 2007
(n = 176)
0 Multiple tumour localizations






Crombie et al. 2012
(n = 54)
36% 53/54 radiochemotherapy
Gomez et al. 2011
(n = 168)
1.2% Multiple tumour localizations
IMRT






Jham et al. 2008
(n = 207)
5.5% Head and neck cancer
Katsura et al. 2008
(n = 39)
15%
Lee et al. 2008
(n = 189)
6.6% Oral cavity and oropharynx
Monnier et al. 2011
(n = 73)
40% Oral cavity and oropharynx
Oh et al. 2004
(n = 81)
4.9%
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The frequency of IORN was almost equal in both groups.
However, the influence of fractionation was interesting.
The rates of IORN were identical after conventional
fractionation over the decades. However, while in group
B an unacceptably high amount of IORN was diagnosed
after hyperfractionation, we did not see any IORN in
group A. One reason may be the reduction of the total
dose from 82.8 Gy to 72 Gy, another one the extension
of the interfraction interval from 4-6 to generally
>6 hours, this relevance of interfractional time intervals
for cell recovery was not yet known during radiotherapy
of group B patients (Fowler, J., personal communication,
approx. 1988).
In the literature, the incidence of IORN varied widely
(0-74%) as depicted in Table 6 whereas the majority of
data are in a range of 5-10%. However, the comparison
of these values to each other and to our results is very
difficult because of a different definition of staging of
IORN, different tumor localizations, therapy schedules,
radiation techniques and dosages results fit well within
the range of data taken from the literature (Kim et al.
1974; Niewald et al. 1996). One of the data sets in the
literature most comparable to our dataset has been pub-
lished by Lee et al. (Lee et al. 2008) who experienced
comparable IORN frequencies in a collective of patients
having been operated on mainly.Reuther et al. 2003
(n = 830)
8.2% Oral cavity and oropharynx












Oral cavity and oropharynx
Conventional dental care vs.
risk-adapted dental care
IMRT
Thiel 1989 4-35% Literature survey
Thorn et al. 2000
(n = 80)
74%/3 years Multiple tumour localizations
Tsai et al. 2012
(n = 402)
7.5% Oropharyngeal cancer, median
time to IORN 8 months
Turner et al. 1996
(n = 333)
5.9%Risk factors for the occurrence of IORN
Numerous prognostic factors for the development of
IORN have been tested and published. A selection of these
is summarized in Table 7. The localization of the primary
tumor in the oral cavity with its microbial colonization
and the abundant involvement of the mandibular bone
with its unique blood supply probably promotes IORN.
Unfavorable dental status, periodontal disease and sore-
ness of the gingiva by pressure triggered by dental pros-
thesis are important as well as dental extractions before
and especially after radiotherapy.
Radiation dose should not exceed 60 – 66 Gy to the
mandibular bone whenever possible, the target volume
extending to the bone should be limited. Some authors
regard hyperfractionation as a risk factor for IORN. In
our ancient publication on this topic (Niewald et al.
1996) we experienced a very high frequency of IORN
after hyperfractionated radiotherapy which may have
been caused by too high total doses on the one hand
and a too short interfraction interval (time interval be-
tween the two daily fractions) on the other hand. Both
factors have been taken into account since 1992, conse-
quently the results were improved markedly.
Intensity modulated radiotherapy (IMRT) has been
found advantageous compared to conventional 3D-plannedradiotherapy. Additional factors may be chemotherapy,
higher body mass index and the use of steroids.
An important paper has been published by Tsai et al.
in 2013 (Tsai et al. 2012). They reviewed the records of
patients with small oropharyngeal cancers having under-
gone radiotherapy or radiochemotherapy. The overall
prevalence of IORN was 7.5%, higher doses, use of nico-
tine and alcohol, dental status as well as more advanced
Table 7 Risk factors for IORN of the upper and lower jaw in the literature
Author group Risk factor(s) Remarks
Ahmed et al. 2009 Intensity modulated radiotherapy (IMRT) advantageous
compared to conventional radiotherapy
Berger and Bensadoun 2010 Total dose >66 Gy Literature survey
Bhide et al. 2012 Total dose > 60 Gy Literature survey
Volume of mandible within the treatment field. Trauma related ORN after
lower doses
IMRT






Lack of pre-RT dental extractions





Mode of radiation delivery
Dental status
Time from radiation therapy until the onset of ORN
Goldwasser et al. 2007 Higher body mass index Multivariate analysis
Use of steroids
Radiation dose >66 Gy
Jereczek-Fossa and Orecchia
2002
Total dose Literature survey, only part of the factions




Volume of the horizontal ramus of the mandible irradiated
with a high dose
Dental status
Bad oral hygiene
Dental extractions after radiotherapy
Katsura et al. 2008 Oral health status after radiotherapy
Periodontal pocket depth
Dental plaque
Alveolar bone loss level
Radiographic periodontal status
Lee et al. 2009 Univariate: Mandibular surgery Multivariate analysis:
Co-60 Mandibular surgery
BED >106.2 Gy
Lozza et al. 1997 Dose rate Brachytherapy exclusively
Reference volume
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Table 7 Risk factors for IORN of the upper and lower jaw in the literature (Continued)
Monnier et al. 2011 Oral cavity tumours Multivariate analysis: bone surgery
Bone invasion
Surgery prior to radiotherapy
Bone surgery
Nabil 2012 Hyperfractionation Literature survey
Reduced risk after accelerated radiotherapy with reduced dose
Reuther et al. 2003 Advanced tumours
Segmental resection of the mandible
Tooth extractions (pre/post RT)
Pre-surgical radiotherapy worse than post-surgical radiotherapy







Dental extractions before and after radiotherapy
Bone surgery because of remaining or recurrent tumours









Turner et al. 1996 Bone involvement
Synchronous Methotrexate
Scattered dose from elective neck treatment
Increasing dose
Increasing target volumes for doses <55 Gy
Dental extractions
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ment of IORN. In contrast to this paper our patients’ pri-
mary situation seems more unfavorable: we only examined
patients with oral cancer where the whole mandible was
within the 100%-isodose, thus we applied even higher
doses to a large amount of bone. Furthermore, older tech-
niques have been used; unfortunately, no information
about fractionation has been given. Consequently, a higher
prevalence of IORN here seems to be explainable.
Unfortunately, we did not succeed in identifying clearly
significant independent prognostic factors for the develop-
ment of IORN. In our patient collective, hyperfractionationseemed to have a protective effect whereas this could not
be examined further due to the small number of events. In
our dataset the number of carious teeth was found to be
the only independent prognostic factor after multivariate
analysis. Univariately, total dose and BED2 were significant
which could be expected. In majority of patients, the total
doses lie in a narrow range of 60-82 Gy which may have
been a reason for the result, additionally the fact that few
IORN cases have been observed.
The authors are well aware of the limitations of this
retrospective evaluation. In this nearly homogenous
collective of patients with oral cavity cancer having
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complete data sets with respect to the dental status
and restoration procedures of nearly all patients. The
IORN data have been investigated meticulously, but
due to the known incompliance of head and neck pa-
tients we could not exclude that single events did not
become known to the authors.Conclusions
The patients’ dental status before radiotherapy was very
poor compared to an otherwise healthy population. Ap-
parently we did not succeed in improving these findings
over the decades despite all effort in terms of dental
prophylaxis. Consequently, extensive dental rehabilitation
procedures had to be performed which did not change
over time as well.
Examining patients irradiated with conventional frac-
tionation, the incidence of IORN was found constant in a
range of 10-15% over time. As stated earlier, the influence
of the interfraction interval and of very high doses became
known after the patients in group B had been irradiated,
we thus diagnosed an unacceptably high frequency of
IORN which became virtually zero after reduction of the
total dose and extension of the interfraction interval. The
multivariate search for prognostic factors only resulted in
the assumption that dental status and fractionation could
influence the occurrence of IORN.
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